Cammarata, E.; Airoldi, C.; Colombo, J.; Ucciero, A.; Mastorino, L.; Arese, V.; Burzi, L.; Castelli, F.; Chiarpenello, M.; Graziola, F.; Leporati, C.; Ortoncelli, M.; Paolo, P.; Pertusi, G.; Pisterna, A.; Quaglino, P.; Ribero, S.; Rossotto, G.; Tiberio, R. .; Dapavo, P.; Savoia, P. Impact of Disease Activity-Guided Dose Reduction on IL-17 and IL-23 Inhibitors in Psoriasis: A Real-World Assessment of Efficacy, Safety, and Economic Benefits. Dermatol Pract Concept 2025, 15 (3), 5845. https://doi.org/10.5826/dpc.1503a5845.